Pulm/Crit Care Flashcards
Indications for IVC filter placement
Complications of anticoagulation (GI bleed, hemorrhagic stroke)
Contraindication to anticoagulation
Failure of anticoagulation in the setting of a known DVT/PE
Lab findings of chronic respiratory acidosis
Elevated bicarb, seen in OSA patients, increases risk of perioperative complications
Wells Criteria
3 points: -Clinical signs of DVT -Alternate diagnosis less likely 1.5 points: -Previous PE or DVT -Tachycardia -Recent surgery or immobilization 1 point: -Hemoptysis -Cancer
If >4, PE likely
Si/Sx of pulmonary embolism
Sudden-onset pleuritic chest pain
Loud P2, pleural friction rub
Hypoxemia
Small pleural effusion on CXR (2/2 inflammation of pulmonary infarct)
Best modality to evaluate pneumothorax in acute setting
Bedside ultrasonography
Causes of nonresolving pneumonia or pulmonary infiltrates
Usually mediated via endobronchial obstruction
Bronchogenic carcinoma (smoker) Carcinoid tumor (younger, non-smoker) Bronchoalveolar cell carcinoma Lymphoma Eosinophilic pneumonia Bronchiolitis obliterans organizing pneumonia (BOOP) Systemic vasculitis Pulmonary alveolar proteinosis Drugs (amiodarone)
Cough-variant asthma
Chronic nonproductive cough, exacerbated by exercise (esp in cold temperatures) or forced expiration or allergens, commonly occurs at night +/- chest tightness
No wheezing or rhonchi on exam
Dx with PFTs
Treat like asthma
Asthma severity: Intermittent Mild persistent Moderate persistent Severe persistent
Based on symptom frequency/SABA use and nighttime awakenings
Intermittent: 2 days or less a week, 2 times or less a month; step 1 (albuterol prn)
Mild persistent: more than 2 days a week but not daily, 3-4 times a month; step 2 (low dose ICS like fluticasone, beclomethasone, budesonide, mometasone)
Moderate persistent: daily, >1 time/week but not nightly; step 3 (low-dose ICS + LABA such as formoterol, salmeterol, olodaterol OR medium-dose ICS)
Severe persistent: throughout the day, 4-7 times a week; step 4/5 (medium to high-dose ICS + LABA, consider omalizumab in patients with allergies
Benign vs malignant patterns of calcification in lung nodules
Benign: popcorn (often seen in pulmonary hamartoma), concentric or laminated, central, diffuse homogeneous
Malignant: eccentric (area of asymmetric calcification), reticular or punctate
Exercise-induced bronchoconstriction
Perform bronchoprovocation testing (exercise or inhalation of cold air): if FEV1 decr by >10% -> positive, if decr by 15% -> diagnostic
Tx with albuterol 10-20min before exercise
Can use mast cell stabilizers (cromolyn) if unable to tolerate SABA
If athlete, start ICS with prn SABA
Endocrine abnormalities caused by lung cancers
Small cell carcinoma: SIADH (normovolemic hyponatremia)
Squamous cell carcinoma: hypercalcemia due to PTH-rP production
Causes of recurrent pneumonia
Aspiration: right middle/lower lobe, dysphagia/dysarthria, altered mentation
Chronic obstructive lung disease: smoking hx, chronic cough, chronic dyspnea
Immunodeficiency
Post-obstructive: hemoptysis, weight loss/cachexia, pneumonia in the same location
Tuberculosis: upper lobe/apical, recent immigrant, institutionalized patient, homeless/lower SES
Tuberculous pleural effusion
Si/Sx: fever, cough, pleurisy and weight loss
Thoracentesis reveals a lymphocyte-predominant, exudative effusion; elevated adenosine deaminase levels
Dx: pleural biopsy
Asthma exacerbation during pregnancy
Supplemental O2 to maintain sats >95%
Nebulized or inhaled albuterol and inhaled ipratropium
If incomplete response, give systemic steroids and observe
Management of choking
If <1: turn face down and give 5 back blows, then turn face up and give 5 chest thrusts
If 1 or more: lean patient forward and give Heimlich (Abdominal thrusts), alternate between back blows and 5 abdominal thrusts, start CPR if becomes unresponsive
PFTs pattern
Restrictive: both FEV1 and FVC are decrease fairly proportionally so FEV1/FVC ratio is normal or increased, reduced total lung capacity
Asthma: usu. normal, decreased FEV1/FVC ratio after methacholine
Pulm. hypertension: normal pattern with decreased DLCO
COPD: reduced FEV1/FVC ratio, DLCO also reduced
Features of classic allergic bronchopulmonary aspergillosis
Hx of asthma, cystic fibrosis Recurrent asthma exacerbation, fever, lethargy, cough with production of brown mucus plugs, fleeting infiltrated on lung imaging Central bronchiectasis on lung CT Dx testing: -Skin test positive for Aspergillus -Eosinophilia >500 -IgE >417 -Speficic IgG and IgE for aspergillus Tx: glucocorticoids and itraconazole
Asthma exacerbation
Mild to moderate (PEF or FEV1 40% or more):
- Inhaled SABA
- PO corticosteroids if no response to SABA or recent steroid use
- O2 if sat <90%
Moderate to severe (<40% PEF or FEV1):
- Inhaled SABA + ipratropium for 1h
- PO/IV steroids
- O2 if sat <90%
Impending or actual resp arrest:
- Inhaled SABA + ipratropium
- IV steroids + mag sulfate
- Consider SQ or IV terbutaline or epinephrine
- O2 or intubation
Manifestations of post-op atelectasis
2-5 days after surgery
ABGs with increased A-a gradient
CXR with linear opacifications in bilateral lung bases